The invention relates to 5-HT receptor modulators, particularly 5-HT.sub.2B antagonists. Novel piperidinylamino-thieno[2,3-d]pyrimidine compounds represented by Formula I, II and III, and uses thereof for treating conditions including pulmonary arterial hypertension, congestive heart failure, and hypertension.

 
Web www.patentalert.com

< Alkynyl aryl carboxamides

> Therapeutic agents for the treatment of cancer, metabolic diseases and skin disorders

> Heterocyclic compounds and their use as aldosterone synthase inhibitors

~ 00556